Chosa Oncology AB (CHOSA)

Chosa Oncology AB recorded one insider purchase during the past ninety days. CEO Peter Buhl acquired shares valued at approximately 294,118 SEK on July 14, 2026. This single transaction represents the entirety of recent market activity, occurring well after the executive's previous acquisition in September 2023.

No insider activity signal

Not featured in screeners

Featured in screeners

No insider activity signal

Not featured in screeners

Insider activity signals

0 activity signals detected for Chosa Oncology AB

No insider activity signals detected

Insider trades have not triggered unusual activity signals for this company.

Top insiders

Company data & Insiders

Subscribe to get access to the company description and key fundamental data (market cap, shares outstanding, dividend yield, % of shares held by insiders and more)

Download results Settings

Trades

Peter Buhl Chief Executive Officer (CEO)/Managing Directory Officer

Transaction date 14 Jul 2026

Purchase

Price

253.07

Quantity 39,815

Value SEK2,998,102

Peter Buhl Chief Executive Officer (CEO)/Managing Directory Officer

Transaction date 13 Sep 2023

Purchase

Price

443.49

Quantity 15,892

Value SEK1,929,938

Notification date	Transaction date	B/S Transaction type	Insider and/or position	Nb. shares Price Value	Number of shares	Price	Value	Details
2026-07-17	2026-07-14	B Purchase	Peter Buhl Chief Executive Officer (CEO)/Managing Directory Officer	39,815 253.07 SEK2,998,102	39,815	253.07	SEK2,998,102
2023-09-13	2023-09-13	B Purchase	Peter Buhl Chief Executive Officer (CEO)/Managing Directory Officer	15,892 443.49 SEK1,929,938	15,892	443.49	SEK1,929,938